B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FLT4

MOLECULAR TARGET

fms related receptor tyrosine kinase 4

NCBI Gene: 232460 compounds

FLT4 (fms related receptor tyrosine kinase 4) is targeted by 60 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FLT4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1erlotinib5.55256
2cabozantinib4.3980
3foretinib4.3476
4tozasertib4.3375
5vandetanib4.3073
6doramapimod4.0657
7quizartinib3.9953
8semaxanib3.9350
9midostaurin3.8546
10brigatinib3.8144
11pazopanib3.6939
12vatalanib3.6939
13nintedanib3.6136
14regorafenib3.5634
15tae 6843.4330
16fedratinib3.4029
17linifanib3.3327
18mln 80543.3327
19tandutinib3.2224
20dovitinib3.0921
21jnj 77066213.0921
22at 92833.0921
23lestaurtinib3.0420
24lenvatinib3.0420
25filgotinib3.0420
26danusertib2.9418
27defosbarasertib2.8917
28r 4062.8316
29cediranib2.8316
30milciclib2.7715
31infigratinib2.7715
32sotrastaurin2.7715
33Sorafenib2.7114
34pha 6657522.7114
35kw 24492.6413
36tivozanib2.6413
37ast 4872.5612
38raf 2652.4811
39motesanib2.4811
40brivanib2.4811
41berzosertib2.309
42su 0148132.208
43rebastinib2.208
44gsk 10709162.208
45enzastaurin2.087
46mk 24612.087
47cep 13472.087
48maleimide1.956
49bastadin 71.956
50cerdulatinib1.956

Showing top 50 of 60 compounds. Use the BiohacksAI search to explore all FLT4 modulators.

About FLT4 as a Drug Target

FLT4 (fms related receptor tyrosine kinase 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 60 compounds with documented FLT4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FLT4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.